June 21 (Reuters) - Genera Biosystems Ltd (GBI) :
- Indian central drugs standard organisation approved importation and sale of genera's upper respiratory tract multiplex molecular diagnostics
- Says license approval is in force for a term of 3 years to June 2019
News: GBI Genera Biosystems receives approval for respiratory tract test in India
Add to My Watchlist
What is My Watchlist?